BiotechTube

micafungin + voriconazole

ApprovedWithdrawn
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Aspergillosis/Blood

Conditions

Aspergillosis/Blood, Aspergillosis/Invasive

Trial Timeline

Feb 1, 2007 → —

NCT ID
NCT00423163

About micafungin + voriconazole

micafungin + voriconazole is a approved stage product being developed by Astellas Pharma for Aspergillosis/Blood. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00423163. Target conditions include Aspergillosis/Blood, Aspergillosis/Invasive.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00423163ApprovedWithdrawn

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85
tolterodine + mirabegronApproved
85